The global AI in drug discovery market is estimated to grow significantly


Preeti18

Uploaded on Aug 28, 2020

Category Business
Category Business

Comments

                     

The global AI in drug discovery market is estimated to grow significantly

Orion Market Research Global IoT Sensors Market, Size, Share, Analysis Report & Forecast to 2026 Request a Free Sample @ https://www.omrglobal.com/request-sample/ai-in-drug- discovery-market Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: [email protected] Contact no: +91 780-304-0404 The global AI in drug discovery market is estimated to grow significantly, at a CAGR of 51.3%, during the forecast period. AI has the potential to enhance the drug discovery process, diminish failure rates during clinical trials, reduce R&D expenses, and ultimately produce a superior medicine for the healthcare sector. There are several drug discovery and pharma companies have started working in conjunction with software companies for implementing the most advanced technologies that require costly and extensive drug discovery process. AI-driven computer programs can accurately and promptly analyze structures of a range of drug molecules and predict adverse effects, potency, and pharmacological activities of the drug. This possibility has the potential to develop a rapid and inexpensive route of drug discovery.   Get Free Sample Copy @ https://www.omrglobal.com/request-sample/ai-in-drug-discovery- market AI stands out to be one of the biggest technological breakthroughs in the healthcare sector; however, there are lots of security concerns associated with this technology, which hampers the growth of the market at the global level. In addition, the lack of relevant data input to AI- assisted healthcare devices may result in hampering the market growth during the forecast period. Despite these restraining factors, with the increasing prevalence of diseases, the need for the advanced drug is rising. Every pharma company strives to develop a new innovative drug. In order to achieve this goal, companies spend heavily on R&D department. These investments are expected to offer growth opportunities to the AI in drug discovery market during the forecast period.  Browse for Full Report Description@ https://www.omrglobal.com/industry-reports/ai-in- drug-discovery-market Market Segmentation  Global AI in Drug Discovery Market by Application  Oncology  CVD  Neurodegenerative Diseases  Others (Metabolic Diseases)  Global AI in Drug Discovery Market by End-User  Pharmaceutical and Biotechnology Companies  Contract Research Organizations (CROs)  Academic Organizations Regional Analysis  North America  United States  Canada  Europe  UK  Germany  Italy  Spain  France  Rest of Europe   Asia-Pacific  China  India  Japan  Rest of Asia-Pacific   Rest of the World Company Profiles  AiCure, LLC  Atomwise, Inc.  BenevolentAI  Biovista  Deep Genomics  Desktop Genetics Ltd.  Exscientia Ltd.  Google LLC  IBM Corp.  IKTOS  Insilico Medicine, Inc.  Intel Corp.  Microsoft Corp.  NuMedii Inc.  Numerate, Inc.  Owkin Inc.  Recursion Pharmaceuticals Inc.  TwoXAR, Inc.  XtalPi Inc. For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/ai-in-drug-discovery-market About Orion Market Research Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. Media Contact: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: [email protected]  Contact no: +91 780-304-0404